PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events
Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey
Objective: The movement disorders society task force for the Middle East (MDS-Task Force for the Middle East) conducted a survey with an aim of characterizing…Istradefylline for daytime sleepiness and sleep disturbances in patients with Parkinson’s disease: an open-label, 3-month study
Objective: To evaluate the effect of istradefylline on daytime sleepiness and sleep disturbances as well as motor symptoms in patients with Parkinson’s disease (PD) in…Improvement on gait in Parkinson’s disease patients using Honda stride management assist device
Objective: To clarify the effect of a wearable exoskeleton stride management assist device (SMAD: Honda R and D Corporation, Japan) on gait in Parkinson's disease…Focused ultrasound subthalamotomy for Parkinson’s disease: A pilot study
Objective: To evaluate feasibility, safety and effectiveness of unilateral subthalamotomy performed with MRIgHIFU to treat the cardinal motor features of PD Background: Ablative functional neurosurgery for…Tozadenant phase 3 study (TOZ-PD) in Parkinson’s disease patients with motor fluctuations: baseline characteristics
Objective: To describe the baseline characteristics of the TOZ-PD study population. Background: Tozadenant is an adenosine A2A antagonist under investigation as an adjunct to levodopa…Evaluation of Brainstem Auditory Evoked Response and Nerve Conduction in Parkinson’s Disease
Objective: The Aim of our study was to evaluate Nerve Conduction Velocity & Brainstem Auditory Evoked Response in patients with Parkinson’s disease. Background: Parkinson’s disease is a progressive…Utility of susceptibility weighted imaging in the objective diagnosis of idiopathic Parkinson’s Disease: Is DaTscan necessary?
Objective: To assess the utility of susceptibility weighted imaging (SWI) in the diagnosis of idiopathic Parkinson’s Disease (IPD) from the movement disorders clinics at the…Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments
Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…Can stimulation of deep brain tissue improve the expression of the mouth in Parkinson’s disease patients?
Objective: To observe if stimulation of deep brain tissue can improve expression of the mouth in Parkinson's disease patients. Background: Masked facies or hypomimia is…
- « Previous Page
- 1
- …
- 345
- 346
- 347
- 348
- 349
- …
- 425
- Next Page »